Efficacy of 5-FU Combined to Na[trans-RuCl(4)(DMSO)Im], A Novel Selective Antimetastatic Agent, on the Survival Time of Mice With P388 Leukemia, P388/DDP subline and MCa Mammary Carcinoma

The combinational treatment between the selective antimetastatic agent, sodium-trans-rutheniumtetrachloridedimethylsulfoxideimidazole, Na[trans-RuCl(4)(DMSO)Im], and the cytotoxic drug 5-fluorouracil (5-FU) on primary tumor growth and on the survival time of experimental tumors results in an effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Coluccia, M., Sava, G., Salerno, G., Bergamo, A., Pacor, S., Mestroni, G., Alessio, E.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364973/
https://www.ncbi.nlm.nih.gov/pubmed/18472766
http://dx.doi.org/10.1155/MBD.1995.195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364973/
https://www.ncbi.nlm.nih.gov/pubmed/18472766
http://dx.doi.org/10.1155/MBD.1995.195

Ejemplares similares